Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Therapeutic Advances in Neurological Disorders|September 14, 2020
Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG)Ayse Altintas, Justina Dargvainiene, Christiane Schneider-Gold, et al.Annals of Clinical and Translational Neurology|December 8, 2022
Neurofilament light chain levels predict encephalopathy and outcome in community-acquired pneumoniaHa-Yeun Chung, Jonathan Wickel, Marcus Oswald, et al.Epilepsia|August 22, 2023
The role of neuronal antibodies in cryptogenic new onset refractory status epilepticusAmanda Eisele, Matthias Schwager, Stefan Yu Bögli, et al.Neurology|October 25, 2023
In Vivo Measurement of Tau Depositions in Anti-IgLON5 Disease Using [18F]PI-2620 PETHendrik Theis, Gérard N Bischof, Norbert Brüggemann, et al.Journal of Neuroimmunology|January 22, 2025
Serum NfL predicts outcome and secondary autoimmunity in herpes-simplex encephalitisKim Kristin Falk, Ligia Abrante Cabrera, Ralf Junker, et al.Frontiers in Immunology|March 4, 2026
Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case reportTorsten Schroeder, Guranda Chitadze, Justina Dargvainiene, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 30, 2025
Longitudinal Blood-Biomarker-Based Assessment of Brain Injury in Patients Undergoing Deep Brain Stimulation and Magnetic Resonance-Guided Focused UltrasoundJustina Dargvainiene, Ann-Kristin Helmers, Juliana Naumann, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 17, 2021
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence regionRobert Markewitz, Antje Torge, Klaus-Peter Wandinger, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 21, 2021
The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273Robert Markewitz, Daniela Pauli, Justina Dargvainiene, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 8, 2022
B-cell responses to vaccination with BNT162b2 and mRNA-1273 6 months after second doseRobert Markewitz, Daniela Pauli, Justina Dargvainiene, et al.Pageof 5